Connect with us

Technology

Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool

The humanitarian move might help the companies gain additional for-profit contracts in the future.

Published

on

Article feature image

Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending